PubMed:10037202 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/10037202","sourcedb":"PubMed","sourceid":"10037202","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/10037202","text":"Clinical use of a new axial chondro-mucosal flap in wide full-thickness eyelid reconstructions.\nBACKGROUND AND OBJECTIVE: Full thickness reconstruction of more than half of an eyelid, mainly of the upper one, is a challenge for the surgeon. In 1992, for the first time, the authors reported the use of an axial chondro-mucosal flap from the nose for reconstruction of the tarsoconjunctival plane of a full thickness defect of an eyelid. This article reports and discusses the results of the follow-up of 18 patients operated on using the above technique during the period June 1991-March 1997.\nPATIENTS AND METHODS: Apart from the oncological evaluation, the following parameters were assessed: position, closure, the presence of epiphora, length of the palpebral rim, rim opening, levator function, an aesthetic balance of the eyelids, and donor site morbidity. The follow-up ranged from 6 to 40 months.\nRESULTS: The axial chondro-mucosal flap was clinically viable in all patients. One patient showed a 2 mm lagophthalmos. Static parameters were within normal ranges. In upper eyelid reconstruction, an 8 to 18 mm. levator function (mean 13 mm) was shown.\nCONCLUSION: The authors discuss their complications and results and feel that this flap, associated with full thickness skin grafts, may be considered a first choice technique, in expert hands, in complex full thickness upper eyelid reconstruction, and a possible alternative in lower eyelid reconstruction, for wide defects when the use of other flaps is compromised.","tracks":[{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":416,"end":435},"obj":"HP_0000492"}],"attributes":[{"subj":"T1","pred":"source","obj":"PubmedHPO"}]},{"project":"PubMed_Structured_Abstracts","denotations":[{"id":"T1","span":{"begin":122,"end":593},"obj":"OBJECTIVE"},{"id":"T2","span":{"begin":616,"end":904},"obj":"METHODS"},{"id":"T3","span":{"begin":914,"end":1157},"obj":"RESULTS"},{"id":"T4","span":{"begin":1170,"end":1526},"obj":"CONCLUSIONS"}],"attributes":[{"subj":"T1","pred":"source","obj":"PubMed_Structured_Abstracts"},{"subj":"T2","pred":"source","obj":"PubMed_Structured_Abstracts"},{"subj":"T3","pred":"source","obj":"PubMed_Structured_Abstracts"},{"subj":"T4","pred":"source","obj":"PubMed_Structured_Abstracts"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PubmedHPO","color":"#e8ec93","default":true},{"id":"PubMed_Structured_Abstracts","color":"#d593ec"}]}]}}